arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Evolus, Inc.

EOLS Health Care Biotechnology: Pharmaceutical Preparations
$6.67
▲ +1.1% Today
as of Jun 7, 07:14 ET
Last 30 days +26.57% Apr 28 → Jun 05
$5.06 $5.50 $5.95 $6.40 $6.84 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$6.60
High
$6.69
Low
$6.36
Volume
$670,704
Avg Vol
$1M
Mkt Cap
$433M
P/E (TTM)
Beta
52w High
$10.62
52w Low
$3.86
Div Yield
Shares Out
$66M

Overview

52-week range
$3.86
$11
42% of range
Avg surprise (last 2)
+4.1%
Avg reaction (last 2)
+3.0%
100% positive
Latest IV / EM
152%
EM ±21.0% · $8 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.32$-0.28$-0.24$-0.20$-0.16 Actual $-0.32Actual $-0.30Actual $-0.22Actual $-0.18Actual $-0.30Actual $-0.25Est $-0.21Actual $-0.27Actual $-0.24Actual $-0.16Est $-0.22 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-19M$5M$29M$53M$77M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 4, 2026Mar/2026 $-0.16 $-0.22 +27.3% +36.0% +4.7% earnings
Tue Sep 30, 2025Sep 2025 $-0.24 financials
Mon Jun 30, 2025Jun 2025 $-0.27 financials
Wed May 7, 2025Mar/2025 $-0.25 $-0.21 -19.1% +1.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.30 financials
Sun Jun 30, 2024Jun 2024 $-0.18 financials
Sun Mar 31, 2024Mar 2024 $-0.22 financials
Sat Sep 30, 2023Sep 2023 $-0.30 financials
Fri Jun 30, 2023Jun 2023 $-0.32 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$73M$69M$69M$69M$61M$67M
Cost of revenue$24M$23M$24M$22M$19M$20M
Gross profit$49M$46M$45M$47M$42M$47M
Operating income$-7M$-12M$-10M$-15M$-15M$-8M
Net income$-11M$-16M$-17M$-19M$-19M$-11M
EPS (diluted)$-0.16$-0.24$-0.27$-0.30$-0.30$-0.18

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$50M$54M$44M$62M$68M$87M$85M$94M
Inventory$25M$27M$33M$26M$10M$12M$15M$13M
Total current assets$139M$143M$135M$145M$132M$151M$150M$158M
Total assets$221M$226M$219M$229M$213M$233M$230M$234M
Long-term debt$156M$146M$146M$145M$122M
Total liabilities$249M$249M$248M$247M$220M$227M$224M$214M
Total equity$-29M$-23M$-29M$-19M$-7M$6M$6M$19M

Implied volatility — last 90 days

146%149%151%154%156% Jun 07 — IV 152% · EM ±21.0%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.